SEC Form 4 · accession 0001493152-26-037500
Hepion Pharmaceuticals, Inc. · HEPA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gary S. Stetz II
Director
Period of report
Aug 3, 2026
Accepted (ET)
Aug 12, 2026 · 9:43 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001583771
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 3, 2026 | P | 500,000 | $0.05 | A | 500,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants | $0.06 | Aug 3, 2026 | P | 500,000 | A | Aug 3, 2026 | Aug 3, 2031 | Common Stock | 500,000 | 500,000 | D |